New hope for Tough-to-Treat throat cancer in Final-Stage trial
NCT ID NCT06118333
Summary
This study is for people with advanced nasopharyngeal cancer (a type of throat cancer) that has returned or spread after they've already tried several other treatments, including immunotherapy and chemotherapy. It aims to see if a new drug called BL-B01D1 works better and is safer than the standard chemotherapy options doctors would normally choose at this stage. Participants are randomly assigned to receive either the new drug or one of the standard chemotherapy treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.